Patient Guide: A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 28 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07043400
Status: 🟢 Enrolling Now
Condition: Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Phase: PHASE3

Where You Can Participate

This study is available at 28 locations across the country.

Top locations include:
  • • Hinsdale, Illinois
  • • Florham Park, New Jersey
  • • Salem, Oregon
  • • And 25 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma - Join Clinical Trial NCTNCT07043400

How to Join This Clinical Trial - NCTNCT07043400

Learn how to participate in this PHASE3 trial studying an investigational therapy for Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT07043400 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 28 locations. Find a study site near you:

Clinical Research Site

Hinsdale, Illinois 60521-0509 - United States

Status: RECRUITING

Clinical Research Site

Florham Park, New Jersey 07932-1049 - United States

Status: RECRUITING

Clinical Research Site

Salem, Oregon 97301 - United States

Status: RECRUITING

Clinical Research Site

Tacoma, Washington 98405 - United States

Status: RECRUITING

Clinical Research Site

São Paulo, 01246-000 - Brazil

Status: RECRUITING

Clinical Research Site

São Paulo, 04501-000 - Brazil

Status: RECRUITING

Clinical Research Site

Vitória, 29043-260 - Brazil

Status: RECRUITING

Clinical Research Site

Beijing, Beijing Municipality 100021 - China

Status: RECRUITING

Clinical Research Site

Zhengzhou, Henan 450052 - China

Status: RECRUITING

Clinical Research Site

Nanjing, Jiangsu 210008 - China

Status: RECRUITING

And 18 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships